LAB UNITED
LAB UNITED is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €548k and a net result of €80k. Equity is growing by ~12% per year across the filed fiscal years. Its solvency ranks better than 83% of 7837 sector peers (fiscal year 2025). The company has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €548k |
| Net result | €80k |
| Staff (FTE) | 1 |
| Better than sector | 83% |
Strong profile, led by solvency.
Computed on 4 of 5 axes. Not measured: health. An unmeasured axis is not a zero: no data was read for it.
This is a financial institution (bank, insurer or financial holding). Our bankruptcy model is trained on ordinary trading and manufacturing companies; a bank balance sheet falls outside that scope. We therefore show no bankruptcy probability rather than a misleading figure.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 85.5% | 51.3% | |
| Net result | €80k | €33k | |
| Equity | €548k | €132k | |
| Gross operating margin | €156k | €63k | |
| Staff costs | €43k | €12k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | n/a | n/a | n/a | n/a | n/a |
| EBITDA | n/a | n/a | n/a | n/a | n/a |
| Net profit | €80k | €99k | €150k | €92k | €102k |
| Cash flow | n/a | n/a | n/a | n/a | n/a |
| Staff costs | €43k | €35k | €33k | €31k | €3k |
| Income taxes | €38k | €41k | €64k | €40k | €47k |
| Dividends | €82k | €0 | €65k | €52k | €43k |
| Total assets | €642k | €643k | €623k | €509k | €480k |
| Equity | €548k | €627k | €528k | €444k | €404k |
| Debt | €93k | €15k | €94k | €65k | €76k |
| of which ≤ 1y | €93k | €15k | €94k | €65k | €76k |
| of which > 1y | - | - | - | - | - |
| Working capital | n/a | n/a | n/a | n/a | n/a |
| Employees (FTE) | 1.0 | 1.0 | 1.0 | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | n/a | n/a | n/a | n/a | n/a |
| Quick ratio | n/a | n/a | n/a | n/a | n/a |
| Working capital ratio | n/a | n/a | n/a | n/a | n/a |
| Solvency | 85.5% | 97.6% | 84.8% | 87.2% | 84.2% |
| Debt / equity | n/a | n/a | n/a | n/a | n/a |
| Long-term debt ratio | n/a | n/a | n/a | n/a | n/a |
| Interest coverage | n/a | n/a | n/a | n/a | n/a |
| Gross margin | n/a | n/a | n/a | n/a | n/a |
| Net margin | n/a | n/a | n/a | n/a | n/a |
| ROA | 12.4% | 15.4% | 24.0% | 18.0% | 21.2% |
| ROE | 14.5% | 15.8% | 28.3% | 20.7% | 25.2% |
| EBITDA margin | n/a | n/a | n/a | n/a | n/a |
| Days sales outstanding | n/a | n/a | n/a | n/a | n/a |
| Days payable outstanding | n/a | n/a | n/a | n/a | n/a |
| Inventory turnover | n/a | n/a | n/a | n/a | n/a |
| Days inventory (DSI) | n/a | n/a | n/a | n/a | n/a |
Full annual accounts (23 line items)
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €642k | €643k | €623k | €509k | €480k |
| Fixed assets | 21/28 | €24k | €29k | €34k | €40k | €56k |
| Tangible fixed assets | 22/27 | €24k | €29k | €34k | €40k | €56k |
| Current assets | 29/58 | €618k | €613k | €588k | €469k | €424k |
| Amounts receivable within one year | 40/41 | €31k | €26k | €67k | €6k | €6k |
| Investments | 50/53 | €480k | €478k | €476k | €200k | €150k |
| Cash & bank | 54/58 | €105k | €109k | €43k | €262k | €267k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €642k | €643k | €623k | €509k | €480k |
| Equity | 10/15 | €548k | €627k | €528k | €444k | €404k |
| Contributions / capital | 10/11 | €12k | €12k | €12k | €12k | €12k |
| Reserves | 13 | €535k | €614k | €515k | €430k | €391k |
| Accumulated profits (losses) | 14 | €1k | €1k | €1k | €1k | €1k |
| Amounts payable | 17/49 | €93k | €15k | €94k | €65k | €76k |
| Amounts payable within one year | 42/48 | €93k | €15k | €94k | €65k | €76k |
| Trade debts payable within one year | 44 | €588 | €486 | €814 | €226 | €1k |
| Income statement | ||||||
| Gross operating margin | 9900 | €156k | €172k | €250k | €180k | €169k |
| Operating result | 9901 | €106k | €130k | €211k | €131k | €149k |
| Financial income | 75 | €12k | €10k | €3k | €82 | €32 |
| Financial charges | 65 | €150 | €135 | €122 | €121 | €120 |
| Result before taxes | 9903 | €118k | €140k | €214k | €131k | €149k |
| Income taxes | 67/77 | €38k | €41k | €64k | €40k | €47k |
| Net result for the period | 9904 | €80k | €99k | €150k | €92k | €102k |
| Result to be appropriated | 9905 | €80k | €99k | €150k | €92k | €102k |
| NACE primary | Activities of holding companies(64210) |
| Legal form | Private limited company(610) |
| Incorporation | 18-01-2005 |
| Status | Active |
| Postal code | 2610 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11051C0126/00B003 | Flanders | 1,452 m² | 1 · 222 m² | 9.6 m · 2 fl. |
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
| Legal nameNL | LAB UNITED |